008930 Stock Chart & Stats
₩44950.00
₩700.00(1.58%)
―
--
Day’s Range― - ―
52-Week Range₩25,600.00 - ₩55,500.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)161.80K
Market Cap
₩3.04T
Enterprise Value₩2.13M
Total Cash (Recent Filing)₩98.28B
Total Debt (Recent Filing)₩183.95B
Price to Earnings (P/E)20.5
Beta0.16
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2188.77
Shares Outstanding68,391,550
10 Day Avg. Volume282,790
30 Day Avg. Volume161,796
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)2.55
Price to Sales (P/S)1.82
P/FCF Ratio85.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Hanmi Science Co., Ltd News
008930 FAQ
What was Hanmi Science Co., Ltd’s price range in the past 12 months?
Hanmi Science Co., Ltd lowest stock price was ₩25600.00 and its highest was ₩55500.00 in the past 12 months.
What is Hanmi Science Co., Ltd’s market cap?
Hanmi Science Co., Ltd’s market cap is ₩3.04T.
When is Hanmi Science Co., Ltd’s upcoming earnings report date?
Hanmi Science Co., Ltd’s upcoming earnings report date is Nov 18, 2026 which is in 86 days.
How were Hanmi Science Co., Ltd’s earnings last quarter?
Hanmi Science Co., Ltd released its earnings results on Aug 14, 2026. The company reported ₩644.5 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Hanmi Science Co., Ltd overvalued?
According to Wall Street analysts Hanmi Science Co., Ltd’s price is currently Undervalued.
Does Hanmi Science Co., Ltd pay dividends?
Hanmi Science Co., Ltd pays a N/A dividend of ₩300 which represents an annual dividend yield of N/A. See more information on Hanmi Science Co., Ltd dividends here
What is Hanmi Science Co., Ltd’s EPS estimate?
Hanmi Science Co., Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hanmi Science Co., Ltd have?
Hanmi Science Co., Ltd has 68,391,550 shares outstanding.
What happened to Hanmi Science Co., Ltd’s price movement after its last earnings report?
Hanmi Science Co., Ltd reported an EPS of ₩644.5 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.113%.
Which hedge fund is a major shareholder of Hanmi Science Co., Ltd?
Currently, no hedge funds are holding shares in KR:008930
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Hanmi Science Co., Ltd
Hanmi Science Co., Ltd. operates through its subsidiaries to produce and distribute pharmaceutical products both within South Korea and internationally. The company's research and development initiatives primarily target treatments for diabetes and various types of cancer. Its extensive product line further includes active pharmaceutical ingredients, general therapeutic drugs, nutritional supplements, and a variety of health-related goods and services. Additionally, it manages an online pharmacy platform and provides automated systems for pharmaceutical administration. The firm, which was initially established as Hanmi Holdings Co., Ltd. in 1973, adopted its current name, Hanmi Science Co., Ltd., in March 2012, and its corporate headquarters are situated in Seoul, South Korea.
Hanall Biopharma Co., Ltd.
―
Celltrion Pharm Inc.
―
Mezzion Pharma Co., Ltd.
―
ST PHARM CO., LTD.
―
SK bioscience Co.,Ltd.
―